News Highlights

Merck says pill reduces hospitalization, death by half
Merck says pill reduces hospitalization, death by half

Merck and Ridgeback Biotherapeutics’ oral antiviral treatment molnupiravir showed reduction of hospitalization or death by around 50% in Covid patients. Plans to seek emergency use authorization.

The World Health Organization Living Guidelines
The World Health Organization Living Guidelines

Contains the organization’s most up-to-date recommendations on drugs to prevent COVID-19, Therapeutics and Clinical management of COVID19. It is updated regularly as new evidence emerges.

COVID-19 Vaccines for Immunocompromised People
COVID-19 Vaccines for Immunocompromised People

People with moderately to severely compromised immune systems are especially vulnerable to COVID-19. An additional dose intended to improve immunocompromised people’s response to their initial vaccine series.